首页> 外国专利> application of totarol and pharmaceutical composition containing totarol

application of totarol and pharmaceutical composition containing totarol

机译:拓他酚的应用及含有拓他酚的药物组合物

摘要

the invention relates to the application of totarol for the production of a preparation for the treatment of inflammations of the bacterial vaginal mucosa membrane, for the relief of symptoms in such treatment and for the prophylaxis and prevention of recurrences of such inflammations. the invention also includes a pharmaceutical composition for the treatment of inflammation of the vaginal mucosa membrane of bacterial origin, for the relief of symptoms in such treatment and for the prophylaxis and prevention of recurrences of such inflammation, the composition containing from 75 to 95 parts in weight of a cellulose derivative, from 0.5 to 5 parts by weight of lactic acid, from 0.5 to 5 parts by weight of a basic polymer, where the stoichiometric ratio of lactic acid to the basic polymer is included in the range from 1: 1 to 8: 1, and comprising totarol in an amount of 0.001 to 5 parts by weight as the active substance.
机译:本发明涉及托他洛尔在制备用于治疗细菌阴道粘膜炎症,减轻这种治疗中的症状以及预防和预防这种炎症复发中的用途。本发明还包括一种药物组合物,用于治疗细菌来源的阴道粘膜的炎症,减轻这种治疗中的症状,以及预防和预防这种炎症的复发,该组合物含有75-95份的药物。纤维素衍生物的重量,乳酸的0.5至5重量份,碱性聚合物的0.5至5重量份,其中乳酸与碱性聚合物的化学计量比为1:1至1 8:1,并包含0.001至5重量份的作为活性物质的甲苯酚。

著录项

  • 公开/公告号BR112019027839A2

    专利类型

  • 公开/公告日2020-07-07

    原文格式PDF

  • 申请/专利权人 EMERGOPHARM SP. Z O.O. SP.K.;

    申请/专利号BR20191127839

  • 发明设计人 ARTUR WRZOSEK;MARIUSZ CIECIARA;

    申请日2018-07-04

  • 分类号A61K9;A61K9/02;A61K9/14;A61K31/05;A61P15/02;

  • 国家 BR

  • 入库时间 2022-08-21 11:18:23

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号